Refine your search with our Advanced Search Tool
Listing contains 128 trial(s)
Liver Cancer, Adult Primary
Phase I/II
A Phase I/II Trial Testing Immunization with afp + Gm-Csf Plasmid Prime And Afp Adenoviral Vector Boost In Patients With Hepatocellular Carcinoma Study Number: 04-101 |
Phase II
A Phase II-a, Open-Label, Randomized Study of JX-594 (Thymidine Kinase-deleted Vaccinia Virus plus GM-CSF) Administered by Intratumoral Injection in Patients with Unresectable Primary Hepatocellular Carcinoma Study Number: 08-096 |
Phase III
A Phase III randomized, double-blind, placebo-controlled study of sorafenib as adjuvant treatment for hepatocellular carcinoma after surgical resection or local ablation Study Number: 08-088 |
Pilot
A Pilot Study of Yttrium-90 Microspheres (SIR-Spheres) Therapy for the Treatment of Unresectable Hepatocellular Carcinoma Study Number: 07-129 |
Evaluation of Image-Guided Liver Surgical System for Resection of Liver Cancer Study Number: 07-130 |
A Pilot Study of Stereotactic Body Radiation Therapy (SBRT) in Combination with Cisplatin Transcatheter Arterial Chemoembolization (TACE) for Primary Hepatocellular Carcinoma (HCC) Study Number: 08-042 |
LC Drug Eluding Bead for Regional Chemoembolization to Downstage Unresectable Hepatocellular Carcinoma (HCC) to Liver Transplantation Study Number: 08-075 |
Tissue and/or blood banking study
Peripheral Blood Collection From Subjects With Cancer or HIV For Use In Research Studies And Immunological Assays Study Number: 04-111 |
About This Web Site
|
Give Us Your Feedback
|
Privacy Statement
|
Disclaimer
|
Informatics Web Resources
©
UPMC, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania
412-647-2811
|
PCI-INFO@upmc.edu
|
Send questions and comments to UPCIwebupdates@upmc.edu
